Sandoz Settles Florida's Generic Drug Price-Fixing Claims

By Bonnie Eslinger · March 3, 2025, 8:58 PM EST

Sandoz AG reached a settlement with Florida that ends federal antitrust claims the Sunshine State lodged against the drugmaker within wider litigation claiming numerous pharmaceutical companies and individuals participated in a...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

Connecticut et al v. Aurobindo Pharma USA, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

December 15, 2016

Case Title

Connecticut et al v. Teva Pharmaceuticals USA, Inc.

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

May 10, 2019

Case Title

Connecticut et al v. Sandoz, Inc. et al

Case Number

Court

Connecticut

Nature of Suit

Anti-Trust

Date Filed

June 10, 2020

Recent Articles By Bonnie

April 18, 2025
Lilly Blasts Compounders' 'Scattershot' Bid To Reverse FDA
April 16, 2025
Blue Shield Of California Sued Over Google's Patient Data Use
April 11, 2025
Amgen Can't Ditch Regeneron's Bundling Antitrust Suit
April 10, 2025
Holmes Seeks Full 9th Circ. Review Of Theranos Fraud Appeal
April 02, 2025
NIH Sued By Researchers Over 'Ideological Purge' On Grants
March 31, 2025
Texas Judge Deems Lab-Test Rule Outside FDA Authority
March 19, 2025
Ohio Opioid Judge Says Texas Court Should Hear Appeal Bid
March 05, 2025
Arizona's 15-Week Abortion Ban Blocked As Unconstitutional
March 03, 2025
Full Fed. Circ. Won't Take On Teva's Orange Book Appeal
February 26, 2025
Merck, Glenmark Trim United Healthcare's Zetia Antitrust Suit